LEGN
Legend Biotech

889
Mkt Cap
$5.17B
Volume
2.94M
52W High
$45.30
52W Low
$27.34
PE Ratio
-21.44
LEGN Fundamentals
Price
$27.53
Prev Close
$28.00
Open
$28.06
50D MA
$32.34
Beta
0.60
Avg. Volume
1.43M
EPS (Annual)
-$0.9686
P/B
5.11
Rev/Employee
$240,534.92
Loading...
Loading...
News
all
press releases
Oversold Conditions For Legend Biotech (LEGN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·1d ago
News Placeholder
More News
News Placeholder
Raiffeisen Bank International AG Makes New $2.67 Million Investment in Legend Biotech Corporation Sponsored ADR $LEGN
Raiffeisen Bank International AG acquired a new position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) in the 2nd quarter, according to the company in its most recent...
MarketBeat·1d ago
News Placeholder
Alberta Investment Management Corp Lowers Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN
Alberta Investment Management Corp cut its stake in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 93.4% in the 2nd quarter, according to the company in its most...
MarketBeat·3d ago
News Placeholder
FY2025 EPS Estimates for Legend Biotech Reduced by Analyst
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) - Equities researchers at Cantor Fitzgerald reduced their FY2025 earnings estimates for Legend Biotech in a research report issued...
MarketBeat·4d ago
News Placeholder
Candriam S.C.A. Boosts Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN
Candriam S.C.A. increased its holdings in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 18.0% during the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·4d ago
News Placeholder
Campbell & CO Investment Adviser LLC Buys Shares of 20,325 Legend Biotech Corporation Sponsored ADR $LEGN
Campbell & CO Investment Adviser LLC purchased a new position in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) during the 2nd quarter, according to the company in its...
MarketBeat·5d ago
News Placeholder
Mitsubishi UFJ Asset Management Co. Ltd. Buys 19,141 Shares of Legend Biotech Corporation Sponsored ADR $LEGN
Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 34.4% in the second quarter, according to its most recent Form 13F...
MarketBeat·5d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Releases Earnings Results, Beats Estimates By $0.02 EPS
Legend Biotech (NASDAQ:LEGN - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of...
MarketBeat·6d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Given New $90.00 Price Target at Barclays
Barclays lowered their price target on Legend Biotech from $94.00 to $90.00 and set an "overweight" rating on the stock in a research note on Thursday...
MarketBeat·6d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Given New $74.00 Price Target at Royal Bank Of Canada
Royal Bank Of Canada reduced their price objective on Legend Biotech from $75.00 to $74.00 and set an "outperform" rating for the company in a research report on Thursday...
MarketBeat·6d ago

Latest LEGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.